Discover

OMER
Omeros Corporation
9.41
2 x 6.90
2 x 12.18
bid
ask
-
0.10
1.05%
2 @ 04:00 PM
9.20 -0.21 (2.23%)
Ytd-45.23%
1y204.53%
9.40
day range
9.73
2.96
52 week range
17.65
Open9.52Prev Close9.51Low9.40High9.73Mkt Cap681.05M
Vol1.41MAvg Vol1.76MEPS1.14P/E8.25Forward P/E-4.32
Beta1.48Short Ratio6.15Inst. Own43.68%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg11.85200-d Avg10.341yr Est43.00

OMER News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation

NEW YORK, July 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
benzinga.com
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

US stock futures up, Nasdaq 100 gains 1%. Biohaven (BHVN) shares down after BofA downgrade and enrol

Omeros stock crashes on regulatory setback: buy the dip?
invezz.com
Omeros stock crashes on regulatory setback: buy the dip?

Omeros Corp (OMER) stock is tumbling on Friday morning following a major regulatory setback in Europ

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu

Crude Oil Falls 4%; US Consumer Sentiment Rises In June
benzinga.com
Crude Oil Falls 4%; US Consumer Sentiment Rises In June

U.S. stocks slightly up, Dow Jones gains 0.1%. Health care shares jump 2.8%, ON Semiconductor down 2

benzinga.com
HC Wainwright & Co. Maintains Buy on Omeros, Lowers Price Target to $33

HC Wainwright & Co. analyst Brandon Folkes maintains Omeros (NASDAQ:OMER) with a Buy and lowe

FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide
benzinga.com
FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide

The European Medicines Agency's Human Medicines Committee (CHMP) on Friday issued a negative opinion

FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide
benzinga.com
FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide

EMA rejects Omeros' Yartemlea for TA-TMA, citing insufficient efficacy data, despite FDA approva

benzinga.com
Omeros Gets EMA CHMP Negative Opinion On Narsoplimab In TA‑TMA; Co. To Request Re‑Examination And Se

Omeros Corporation (NASDAQ:OMER) announced today an update on the review by the Committee for Medici

Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
businesswire.com
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) announced today an update on the review

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m

ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
benzinga.com
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fa

benzinga.com
HC Wainwright & Co. Reiterates Buy on Omeros, Maintains $40 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Omeros (NASDAQ:OMER) with a Buy and mai